SKI Market

Indian Indices

Sensex

82,626.76 -1,048.16
( -1.25%)

Global Indices

Nasdaq

49,514.94 41.95
(0.08%)

Dow Jones

6,856.39 2.63
(0.04%)

Hang Seng

57,040.53 -599.31
(-1.04%)

Nikkei 225

10,448.94 46.50
(0.45%)

Forex

USD-INR

90.59 -0.07
(-0.07%)

EUR-INR

107.56 -0.26
(-0.24%)

GBP-INR

123.48 -0.32
(-0.26%)

JPY-INR

0.59 0.00
(0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Valiant Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543998

INE0JWS01017

58.4359033

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VALIANTLAB

63.4

334.02

EPS(TTM)

Face Value()

Div & Yield %

0.97

Back

Gabriel India consolidated net profit declines 9.05% in the December 2025 quarter

Feb 03,2026

Net profit of Gabriel India declined 9.05% to Rs 54.67 crore in the quarter ended December 2025 as against Rs 60.11 crore during the previous quarter ended December 2024. Sales rose 15.94% to Rs 1178.66 crore in the quarter ended December 2025 as against Rs 1016.57 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	1178.66	1016.57	16
OPM %	9.07	9.00	-
PBDT	110.72	97.94	13
PBT	85.24	78.53	9
NP	54.67	60.11	-9

82,626.76 -1,048.16 ( -1.25%)

49,514.94 41.95 (0.08%)

6,856.39 2.63 (0.04%)

57,040.53 -599.31 (-1.04%)

10,448.94 46.50 (0.45%)

90.59 -0.07 (-0.07%)

107.56 -0.26 (-0.24%)

123.48 -0.32 (-0.26%)

0.59 0.00 (0.20%)